Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Genelux Corporation, 3 years.
Genelux Corporation
Director
NewAmsterdam Pharma Company N.V.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 1, 2024 | Genelux Corporation | Grant or award | +39,541 | — | — |
| May 29, 2024 | Genelux Corporation | Open-market purchase | +6,250 | — | — |
| Feb 13, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +2,793 | — | — |
| Feb 13, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +8,572 | — | — |
| Sep 13, 2023 | Genelux Corporation | Open-market sale | −900 | $20.78 | $18,702 |
| Sep 11, 2023 | Genelux Corporation | Grant or award | +6,920 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.